Both PRP (Platelet Rich Plasma) therapy and QR678 Neo offer solutions designed to address hair loss. However, understanding their unique approaches and benefits can help you make an informed decision.
PRP (Platelet Rich Plasma) therapy involves using a concentrated component of your blood, rich in platelets and plasma, to stimulate hair follicles. Platelets, the body's natural healers, release growth factors and proteins that encourage follicular repair and regrowth.
Blood is drawn, processed to extract the platelet-rich plasma, and injected into areas of hair thinning.
PRP may improve hair count, thickness, and growth phase.
Results can vary, and ongoing research is evaluating its long-term efficacy.
Involves blood extraction and preparation, which may cause mild discomfort.
Parameter | PRP Therapy | QR678 Neo |
---|---|---|
Source | Riskier: Derived from the patient's blood. | Safe: Plant-derived biomimetic growth factors. |
Procedure | Cumbersome: Blood is drawn, processed, and injected. | Efficient: Quick 10-minute, chair-side injection. |
Pain Level | Painful: Discomfort during blood draw and injection. | Painless: Administration without deeper pricks. |
Downtime | Yes: May vary based on patient tolerance. | No: Minimal to no downtime. |
Efficacy | Mid: Promising results but still under research. | High: Clinically proven with consistent outcomes. |
Convenience | Low: Requires blood extraction and preparation. | High: No blood work or additional prep required. |
Formulation | May contain inhibitory growth factors as well. | Contains only stimulatory growth factors. |
Targeted biomimetic polypeptides specific to hair loss.
Backed by 14+ clinical research papers.
Non-invasive, no risk of infections, safe.
No sticky scalp, headaches, or downtime.
Strong, thick, resilient hair—made to last.
10-minute chairside procedure; visible results in 8-10 sessions.
24.8% improvement in Global Hair Growth and Quality scores while using the QR678 Suite with QR678 Neo therapy.
Hair Rub Test showed reduced hair fall from 4.54* (baseline) to 1.49* (post-therapy) for over 80% users.
Reduces hair loss, improves texture, shine, and density.
*Reference: Kapoor, R., & Shome, D. (2024, August). Evaluation of the effectiveness of the QR678 Suite in combination with QR678 Neo therapy for managing Androgenetic Alopecia: A prospective clinical study.